St. Luke’s Cancer Center

St. Luke’s Cancer Center is a comprehensive oncology treatment and research facility integrated within the St. Luke’s University Health Network, serving patients across Pennsylvania and New Jersey. The center provides a full spectrum of cancer care services, including medical oncology, radiation therapy, and specialized surgical oncology supported by advanced diagnostic imaging and genetic testing. As a member of the Memorial Sloan Kettering (MSK) Cancer Alliance, the center offers patients access to high-level clinical trials and innovative treatment protocols typically found at major academic medical centers. Its research program is heavily involved in Phase 1 through Phase 3 clinical trials, focusing on novel therapeutic modalities such as immunotherapies and targeted molecular agents. St. Luke’s is recognized for its multidisciplinary approach, combining state-of-the-art technology with personalized patient navigation and supportive care services.